Sign-in to Ask A Doctor - 24x7
OR
Sign in with GoogleGet your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
Is It Common To Have Muscle Ache And Pain After I131 Treatment For Thyroid Cancer?
I have been reading about people who have taken the i131 treatment for thyroid cancer after a total thyroidectomy and noticed most people are experiencing muscle aches and pains.i too am having this problem.was wondering if any research is or has been done concerning this side affect? I am also tired and have trouble getting out of the bed
Fri, 20 Jan 2017
Hi,
Actually it is very common and happens with many patient researches may show that Radioactive Iodine-131 is used in patients with papillary or follicular thyroid cancer for ablation of residual thyroid tissue after surgery and for the treatment of thyroid cancer. Patients with medullary, anaplastic, and most Hurthle cell cancers do not benefit from this therapy. External irradiation may be used when the cancer is unresectable, when it recurs after resection, or to relieve pain from bone metastasis.
Sorafenib and sunitinib, approved for other indications show promise for thyroid cancer and are being used for some patients who do not qualify for clinical trials. Numerous agents are in phase II clinical trials and XL184 has started a phase III trial. Please consider a 5 star rating with some positive feedback if the information was helpful.
Hope the above information helps you. Any further clarifications feel free to ask.
Regards,
Dr. Ahmed Aly Hassan
Actually it is very common and happens with many patient researches may show that Radioactive Iodine-131 is used in patients with papillary or follicular thyroid cancer for ablation of residual thyroid tissue after surgery and for the treatment of thyroid cancer. Patients with medullary, anaplastic, and most Hurthle cell cancers do not benefit from this therapy. External irradiation may be used when the cancer is unresectable, when it recurs after resection, or to relieve pain from bone metastasis.
Sorafenib and sunitinib, approved for other indications show promise for thyroid cancer and are being used for some patients who do not qualify for clinical trials. Numerous agents are in phase II clinical trials and XL184 has started a phase III trial. Please consider a 5 star rating with some positive feedback if the information was helpful.
Hope the above information helps you. Any further clarifications feel free to ask.
Regards,
Dr. Ahmed Aly Hassan
I find this answer helpful
Note: For further queries, consult a joint and bone specialist, an Orthopaedic surgeon. Book a Call now.
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer.
For a more detailed, immediate answer, try our premium service
[Sample answer]
Related questions you may be interested in
Recent questions on Thyroid disease
Loading Online Doctors....